Press Release | Pharmadule Morimatsu AB
Nacka, Stockholm: - Pharmadule Morimatsu has been awarded
the contract for design, fabrication, site installation and
start-up of a state-of-the-art modular biomanufacturing plant in
the US. The basic design was completed earlier this year and
delivery and completion is scheduled for 2019. The owner will
leverage the off-site fabrication of modular construction and
complete site work in parallel to optimize the overall schedule and
begin qualification and production activities much earlier than can
be achieved with conventional stick-built construction. This
will allow the owner to more quickly gain a return on
investment.
Pharmadule Morimatsu AB is the Swedish-based global leader in
the delivery of modular facilities to the Life Sciences
Industry. Utilizing multidisciplinary expertise, including
Process and Facility Engineering, Pharmadule is able to provide
turnkey solutions anywhere in the world quickly, efficiently and
cost effectively.